You are here

  • Home
  • Archive
  • Volume 10, Issue 3
  • PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+ T cell-dependent antitumor immunity and abscopal effect after local irradiation

Article metrics

Article menu
Oncolytic and local immunotherapy
Original research
PI3Kδ/γ inhibitor BR101801 extrinsically potentiates effector CD8+ T cell-dependent antitumor immunity and abscopal effect after local irradiation

 

Online download statistics by month:

Online download statistics by month: March 2022 to February 2026

AbstractFullPdf
Mar 2022485524234
Apr 202218218680
May 202216417465
Jun 202215816360
Jul 202211311444
Aug 202212412833
Sep 202213614347
Oct 202211816944
Nov 2022949447
Dec 2022818124
Jan 2023757535
Feb 2023878716
Mar 2023505039
Apr 2023424214
May 2023353614
Jun 2023505010
Jul 2023535333
Aug 2023515116
Sep 2023565634
Oct 2023414116
Nov 2023535918
Dec 2023485114
Jan 2024414129
Feb 2024454514
Mar 2024565679
Apr 2024535318
May 2024596022
Jun 2024414712
Jul 2024747424
Aug 2024424364
Sep 2024454489
Oct 2024494984
Nov 2024293012
Dec 2024394021
Jan 2025596039
Feb 202520220324
Mar 2025626334
Apr 2025767640
May 2025484936
Jun 2025303010
Jul 2025110
Feb 2026110
Total334834921588